Use access key #2 to skip to page content.
  • S&P 500: 1,091.38
  • Change: -0.32%
$17.55 0.12 (0.69%)
11/20/2009 4:00 PM

Mylan Laboratories, Inc. (MYL)

CAPS Rating:
***

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating MYL

Add Stock to Watchlist

What the Community Thinks

Total Members

509 Outperforms
36 Underperforms
 

All-Stars

146 Outperforms
8 Underperforms
 

Wall Street

15 Outperforms
1 Underperforms
 

Members bullish on MYL are also bullish on:

Members bearish on MYL are also bearish on:

Ticker Tags

Pharmaceuticals (150), Healthcare (733), Mid Cap (589), S&P 500 (500), Distressed (1623), Defensive (1498)
Suggest a tag

Mylan Laboratories, Inc. At A Glance

Current Price: $17.55
Last Trade Time: 11/20/2009 4:00 PM
Open: $17.44
Previous Close: $17.43
Daily Range: $17.31 - $17.63
52-Week Range: $7.09 - $18.10
Volume: 4,093,232
Market Cap: $5.36B
P/E Ratio: 108.94
Compare Our Special Broker Offers!

Stock Trends

MYL VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

3

Mylan Laboratories, Inc. (MYL)

Avatar RXDOC73 (99.17) Submitted: 10/28/08 3:44 PM

The population is just getting older and more people are going to need more drugs. There is a great deal of consolidation in the field and only the strong companies like this one will survive the fallout.

Also a great takeover target for the likes of TEVA.

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

3

Mylan Laboratories, Inc. (MYL)

Avatar DouglasRich (< 20) Submitted: 1/29/08 9:30 AM

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes more expensive products. Teva and Dr. Reddy are t...More

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 92 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (MYL)

Avatar stockfreak1 (< 20) Submitted: 11/13/09 3:16 PM : Underperform Start Price: $17.54 MYL Score: -0.01

If this stock actually gave me points I would upthumb it.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar bobsweet (30.71) Submitted: 9/28/09 9:17 AM : Outperform Start Price: $16.15 MYL Score: 4.30

Love the company. Generic medicine will boost with Obamas healtcare plan. Not to mention new FDA approvals, including HIV pill approval. I am just waiting for this comapny to explode!!!!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar dutchredneck (41.60) Submitted: 9/23/09 10:30 AM : Outperform Start Price: $16.11 MYL Score: 6.72

Growth stock will outperform the S&P.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar 8tune (62.96) Submitted: 9/09/09 1:46 PM : Outperform Start Price: $14.27 MYL Score: 17.08

Mylan generic pharma to outperform S&P.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MYL)

Avatar NOFY (58.79) Submitted: 8/10/09 10:25 AM : Outperform Start Price: $13.27 MYL Score: 23.39

Baby boomers, many drugs going generic soon.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 92 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 16 of 16  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRBCCapMkts 82.07 04/23/09 Outperform NS $14.49+21.12%+30.54%-9.42
TrackBarclaysCap 86.21 02/23/09 Outperform NS $12.99+35.10%+42.29%-7.18
TrackStanfordRes 78.48 09/25/08 Outperform NS $12.02+46.01%-6.05%+52.06
TrackNeedham < 20 09/25/08 Outperform NS $12.02+46.01%-6.05%+52.06
TrackScottBleier 59.56 06/13/08 Outperform 3M $12.59+39.40%-16.65%+56.05
TrackSoros 24.12 03/31/08 Outperform NS $11.60+51.29%-14.01%+65.30 Toggle the visibility of 60-Second Pitch and replies
TrackCitigroup < 20 03/14/08 Outperform NS $11.17+57.12%-14.11%+71.22
TrackPatDorsey 71.52 01/04/08 Outperform 5Y $13.69+28.20%-19.29%+47.49
TrackBofASec 91.37 12/18/07 Outperform NS $13.80+27.17%-21.53%+48.70
TrackBernstein 83.44 11/15/07 Outperform NS $14.27+22.99%-21.78%+44.76
TrackJPMorgan 73.67 10/04/07 Outperform NS $17.21+1.98%-25.61%+27.58
TrackDreman 88.71 09/30/07 Outperform NS $15.96+9.96%-24.86%+34.82 Toggle the visibility of 60-Second Pitch and replies
TrackCreditSuiss 90.95 09/10/07 Outperform NS $15.59+12.57%-21.38%+33.95
TrackUBS 88.39 09/10/07 Outperform NS $15.59+12.57%-21.38%+33.95
TrackMatrix 87.46 11/20/06 Outperform NS $20.67-15.11%-17.18%+2.07
TrackJimCramer 36.31 08/09/06 Underperform 3W $19.75-11.13%-8.61%+2.52

Results 1 - 16 of 16  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD02 0ms